Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 13
2003 9
2004 16
2005 22
2006 20
2007 15
2008 13
2009 16
2010 21
2011 24
2012 31
2013 28
2014 29
2015 30
2016 23
2017 48
2018 52
2019 48
2020 67
2021 70
2022 73
2023 78
2024 84
2025 102
2026 37

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

833 results

Results by year

Filters applied: . Clear all
Page 1
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DRW, Jha V, Liew A, Liu ZH, Mejía-Vilet JM, Nester CM, Radhakrishnan J, Rave EM, Reich HN, Ronco P, Sanders JF, Sethi S, Suzuki Y, Tang SCW, Tesar V, Vivarelli M, Wetzels JFM, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli MA, Cheung M, Earley A, Floege J. Rovin BH, et al. Among authors: suzuki y. Kidney Int. 2021 Oct;100(4):753-779. doi: 10.1016/j.kint.2021.05.015. Kidney Int. 2021. PMID: 34556300 Free article.
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG; ENVISION Trial Investigators Group. Mathur M, et al. Among authors: suzuki y. N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2. N Engl J Med. 2024. PMID: 37916620 Free PMC article. Clinical Trial.
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.
Perkovic V, Trimarchi H, Tesar V, Lafayette R, Wong MG, Barratt J, Suzuki Y, Liew A, Zhang H, Carroll K, Jha V, Quevedo A, Han SH, Praga M, Chacko B, Sahay M, Cheung CK, Kooienga L, Walsh M, Xia J, Fajardo C, Shah L, Hafkin J, Rizk DV; VISIONARY Trial Investigators Group. Perkovic V, et al. Among authors: suzuki y. N Engl J Med. 2026 Feb 12;394(7):635-646. doi: 10.1056/NEJMoa2512133. Epub 2025 Nov 8. N Engl J Med. 2026. PMID: 41211929 Clinical Trial.
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Craig TJ, Reshef A, Li HH, Jacobs JS, Bernstein JA, Farkas H, Yang WH, Stroes ESG, Ohsawa I, Tachdjian R, Manning ME, Lumry WR, Saguer IM, Aygören-Pürsün E, Ritchie B, Sussman GL, Anderson J, Kawahata K, Suzuki Y, Staubach P, Treudler R, Feuersenger H, Glassman F, Jacobs I, Magerl M. Craig TJ, et al. Among authors: suzuki y. Lancet. 2023 Apr 1;401(10382):1079-1090. doi: 10.1016/S0140-6736(23)00350-1. Epub 2023 Feb 28. Lancet. 2023. PMID: 36868261 Clinical Trial.
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.
Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Er L, Espino-Hernandez G, Kim SJ, Reich HN, Feehally J, Cattran DC; International IgA Nephropathy Network. Barbour SJ, et al. Among authors: suzuki y. JAMA Intern Med. 2019 Jul 1;179(7):942-952. doi: 10.1001/jamainternmed.2019.0600. JAMA Intern Med. 2019. PMID: 30980653 Free PMC article.
Targeting APRIL in the treatment of glomerular diseases.
Cheung CK, Barratt J, Lafayette R, Liew A, Suzuki Y, Tesař V, Trimarchi H, Wong MG, Zhang H, Rizk DV. Cheung CK, et al. Among authors: suzuki y. Kidney Int. 2024 Nov;106(5):806-818. doi: 10.1016/j.kint.2024.08.012. Epub 2024 Sep 7. Kidney Int. 2024. PMID: 39182759 Review.
Galectin-3 contributes to pathogenesis of IgA nephropathy.
Chou YL, Chen HL, Hsu BG, Yang CY, Chen CH, Lee YC, Tsai IL, Sung CC, Wu CC, Yang SR, Suzuki Y, Yates E, Hua KF, Yu LG, Liu FT, Chen A, Ka SM. Chou YL, et al. Among authors: suzuki y. Kidney Int. 2024 Oct;106(4):658-670. doi: 10.1016/j.kint.2024.06.023. Epub 2024 Jul 29. Kidney Int. 2024. PMID: 39084257
Lessons from IgA Nephropathy Models.
Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M, Lee M, Aoki R, Yamada K, Muto M, Suzuki Y. Kano T, et al. Among authors: suzuki y. Int J Mol Sci. 2024 Oct 25;25(21):11484. doi: 10.3390/ijms252111484. Int J Mol Sci. 2024. PMID: 39519036 Free PMC article. Review.
833 results